AAD: Guidelines for Management of Atopic Dermatitis

Zusammenfassung

Evidence-based guidelines for atopic dermatitis/eczema management

Kerninformationen

as well as new systemic treatments (e. g. biologics and JAK inhibitors). Analysis of the evidence from a systematic view resulted in 11 evidence-based recommendations. The guidelines strongly recommend the use of:*Dupilumab;Tralokinumab;Abrocitinib;Baricitinib; andUpadacitinib. The guidelines condi...

substance use, ADHD, and elements of metabolic syndrome. Evidence suggests a small association with various cardiovascular conditions. The association between AD in adults and autism spectrum disorders, myocardial infarction, stroke, and metabolic syndrome as a whole is uncertain. Clinicians shou...

assessment, safety, and efficacy of treatments for AD. Section 1: Diagnosis and assessment of atopic dermatitisSection 2: Management and treatment of atopic dermatitis with topical therapiesSection 3: Management and treatment with phototherapy and systemic agentsSection 4: Prevention of disease fla...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen